DailyStocks Stock Article Search

https://seekingalpha.com/news/4146373-emergent-bio-stock-slips-financing-deal?source=feed_sector_healthcare Sep 03, 2024 - Emergent BioSolutions (EBS) stock as company plans to issue shares of its common stock and warrants as part of a credit deal with Oak Hill Advisors. Read more here. 0

https://www.zacks.com/stock/news/2330291/is-entera-bio-entx-outperforming-other-medical-stocks-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-2330291 Sep 02, 2024 - Here is how Entera Bio Ltd. (ENTX) and Akebia Therapeutics (AKBA) have performed compared to their sector so far this year. 0

https://www.zacks.com/stock/news/2326319/kala-bio-kala-may-find-a-bottom-soon-here-s-why-you-should-buy-the-stock-now?cid=CS-ZC-FT-tale_of_the_tape|hammer_chart_pattern_(ta)-2326319 Aug 23, 2024 - KALA BIO (KALA) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term. 0

https://www.zacks.com/stock/news/2325561/after-plunging-23-49-in-4-weeks-here-s-why-the-trend-might-reverse-for-kronos-bio-kron?cid=CS-ZC-FT-tale_of_the_tape|rsi-2325561 Aug 22, 2024 - Kronos Bio (KRON) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock. 0

https://www.zacks.com/stock/news/2322719/all-you-need-to-know-about-entera-bio-entx-rating-upgrade-to-buy?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2322719 Aug 15, 2024 - Entera Bio (ENTX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). 0

https://seekingalpha.com/news/4139828-bluebird-bio-stock-slips-lowered-guidance?source=feed_sector_healthcare Aug 14, 2024 - bluebird Bio (BLUE) stock fell as the company lowered the full-year outlook, while its Q2 results exceeded expectations. Read more here. 0

https://www.zacks.com/stock/news/2321621/gritstone-bio-inc-grts-reports-q2-loss-misses-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2321621 Aug 13, 2024 - Gritstone bio (GRTS) delivered earnings and revenue surprises of 38.46% and 66.70%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://seekingalpha.com/article/4713866-belite-bio-inc-2024-q2-results-earnings-call-presentation?source=feed_all_articles Aug 12, 2024 - 0

https://seekingalpha.com/article/4713865-belite-bio-inc-blte-q2-2024-earnings-call-transcript?source=feed_sector_transcripts Aug 12, 2024 - Belite Bio, Inc (NASDAQ:NASDAQ:BLTE) Q2 2024 Earnings Conference Call August 12, 2024 4:30 PM ETCompany ParticipantsTom Lin - Chairman and Chief Executive... 0

https://seekingalpha.com/article/4713850-tela-bio-inc-tela-q2-2024-earnings-call-transcript?source=feed_sector_transcripts Aug 12, 2024 - TELA Bio, Inc. (NASDAQ:NASDAQ:TELA) Q2 2024 Results Conference Call August 12, 2024 4:30 PM ETCompany ParticipantsLouisa Smith - Vice President of Gilmartin... 0